Networks for functional regulation of pancreatic acinar-ductal metaplasia and epithelial plasticity

胰腺腺泡导管化生和上皮可塑性的功能调节网络

基本信息

  • 批准号:
    9977159
  • 负责人:
  • 金额:
    $ 36.45万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-07-01 至 2022-03-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY The exocrine pancreas has a remarkable ability to regenerate after injury, as illustrated in acute pancreatitis, and subsets of chronic pancreatitis. Acinar-ductal metaplasia (ADM) is critical in the ability of the exocrine pancreas to regenerate or permit progression to a preneoplastic state (pancreatic intraepithelial neoplasia or PanIN). Expression of oncogenic Kras* (=mutant Kras) in the mouse pancreas leads to formation of PanIN lesions with long latency, indicating the need for genetic and possibly epigenetic “second hits”. Chronic pancreatitis is recognized as a strong risk factor for pancreatic ductal adenocarcinoma (PDA) in humans. In mouse models of pancreatic cancer, induction of either acute or chronic pancreatitis results in tissue-wide ADM that is followed by rapid repair (we designate this as “Adaptive” ADM). However, in the presence of oncogenic Kras*, repair is impaired and ADM progresses to PanIN lesions (we designate this as “Oncogenic” ADM). Currently, the mechanisms underlying the formation of ADM and how ADM progresses to PanIN in the presence of mutant Kras* remain unknown. Recently, our group performed gene expression analysis of murine ductal cells isolated from the developing pancreas, acute pancreatitis (ADM), and PanIN expressing oncogenic KrasG12D, and compared the expression profiles to that of normal pancreatic ductal cells, resulting in nearly 80 potential genes of interest. Prrx1 (paired-related homeobox 1) was the most differentially regulated transcription factor in all three processes, followed by Etv5, a member of the Ets family of transcriptional factors. Based upon compelling published and preliminary data, we hypothesize that Etv5 and Prrx1 are involved in the initiation and maintenance of ADM, respectively, following pancreatitis. Furthermore, we hypothesize that this regulation allows for subsequent transformation by oncogenic Kras*, thereby promoting progression to PanIN. This hypothesis will be tested through the following interrelated Specific Aims: (1) To determine if Prrx1 is required for ADM and PanIN following pancreatic injury; (2) To elucidate the relationship between Etv5 and Sox9 in the functional regulation of ADM; and (3) To identify and evaluate gene targets of Prrx1 and iKras* (inducible mutant Kras) in the development of “Oncogenic” ADM (to PanIN). This aim will identify effectors of Prrx1 and iKras*. Our innovative and integrated research will define the transcriptional regulation of ADM and provide a basis for new perspectives in the therapy of pancreatitis and PanIN.
项目总结

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Anil K Rustgi其他文献

EGFR inhibitors eliminate esophageal cancer stem cells by suppressing epithelial-mesenchymal transition.
EGFR 抑制剂通过抑制上皮间质转化来消除食道癌干细胞。
  • DOI:
  • 发表时间:
    2014
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Mitsuteru Natsuizaka;Bongani Kaimila;Yoshimasa Kubota;Yutaka Hatanaka;Katsuji Marukawa;Katsumi Terashita;Fumiyuki Sato;Shunsuke Ohnishi;Goki Suda;Shinya Ohashi;Shingo Kagawa;Kelly Whelan;Anil K Rustgi;Hiroshi Nakagawa;Naoya Sakamoto
  • 通讯作者:
    Naoya Sakamoto

Anil K Rustgi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Anil K Rustgi', 18)}}的其他基金

ORION: Oncology Research Integration using OHDSI-based NLP (NCI Cancer Informatics Scholar)
ORION:使用基于 OHDSI 的 NLP 进行肿瘤学研究整合(NCI 癌症信息学学者)
  • 批准号:
    10891217
  • 财政年份:
    2023
  • 资助金额:
    $ 36.45万
  • 项目类别:
Core A - Administrative and Biostatistics Core
核心 A - 行政和生物统计核心
  • 批准号:
    10493658
  • 财政年份:
    2021
  • 资助金额:
    $ 36.45万
  • 项目类别:
Mechanisms of Esophageal Carcinogenesis
食管癌发生机制
  • 批准号:
    10305930
  • 财政年份:
    2021
  • 资助金额:
    $ 36.45万
  • 项目类别:
Project 2: Characterization of microenvironmental drivers of neoplasia in BE
项目 2:BE 肿瘤形成微环境驱动因素的表征
  • 批准号:
    9277751
  • 财政年份:
    2017
  • 资助金额:
    $ 36.45万
  • 项目类别:
Weight loss-induced Microbiome and Adipokine Changes in Barrett's Esophagus
减肥引起的巴雷特食管微生物组和脂肪因子变化
  • 批准号:
    8844119
  • 财政年份:
    2011
  • 资助金额:
    $ 36.45万
  • 项目类别:
Stem Cells And The Origins of Barrett's Esophagus
干细胞和巴雷特食管的起源
  • 批准号:
    8208253
  • 财政年份:
    2011
  • 资助金额:
    $ 36.45万
  • 项目类别:
Project 2: Characterization of microenvironmental drivers of neoplasia in BE
项目 2:BE 肿瘤形成微环境驱动因素的表征
  • 批准号:
    10183179
  • 财政年份:
    2011
  • 资助金额:
    $ 36.45万
  • 项目类别:
Stem Cells And The Origins of Barrett's Esophagus
干细胞和巴雷特食管的起源
  • 批准号:
    9325648
  • 财政年份:
    2011
  • 资助金额:
    $ 36.45万
  • 项目类别:
Stem Cells And The Origins of Barrett's Esophagus
干细胞和巴雷特食管的起源
  • 批准号:
    8535691
  • 财政年份:
    2011
  • 资助金额:
    $ 36.45万
  • 项目类别:
Stem Cells And The Origins of Barrett's Esophagus
干细胞和巴雷特食管的起源
  • 批准号:
    8731824
  • 财政年份:
    2011
  • 资助金额:
    $ 36.45万
  • 项目类别:

相似海外基金

Regulation of acinar cell function
腺泡细胞功能的调节
  • 批准号:
    RGPIN-2018-06444
  • 财政年份:
    2022
  • 资助金额:
    $ 36.45万
  • 项目类别:
    Discovery Grants Program - Individual
Regulation of acinar cell function
腺泡细胞功能的调节
  • 批准号:
    RGPIN-2018-06444
  • 财政年份:
    2021
  • 资助金额:
    $ 36.45万
  • 项目类别:
    Discovery Grants Program - Individual
Regulation of acinar cell function
腺泡细胞功能的调节
  • 批准号:
    RGPIN-2018-06444
  • 财政年份:
    2020
  • 资助金额:
    $ 36.45万
  • 项目类别:
    Discovery Grants Program - Individual
Elucidation of the developmental mechanism of pancreatic acinar cell metaplasia in stomach
胃胰腺腺泡细胞化生发育机制的阐明
  • 批准号:
    20K16985
  • 财政年份:
    2020
  • 资助金额:
    $ 36.45万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Research on carcinogenesis and cell differentiation using established human pancreatic acinar cell carcinoma cell line
利用已建立的人胰腺腺泡细胞癌细胞系进行癌发生和细胞分化的研究
  • 批准号:
    19K07518
  • 财政年份:
    2019
  • 资助金额:
    $ 36.45万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Characterization of SPCA2C in acinar cell function
SPCA2C 在腺泡细胞功能中的表征
  • 批准号:
    539767-2019
  • 财政年份:
    2019
  • 资助金额:
    $ 36.45万
  • 项目类别:
    University Undergraduate Student Research Awards
Regulation of acinar cell function
腺泡细胞功能的调节
  • 批准号:
    RGPIN-2018-06444
  • 财政年份:
    2019
  • 资助金额:
    $ 36.45万
  • 项目类别:
    Discovery Grants Program - Individual
The study to detect early-stage pancreatic cancer based on the data from molecular biology about the atrophic acinar cell surrounding carcinoma in situ.
该研究基于原位癌周围萎缩性腺泡细胞的分子生物学数据来检测早期胰腺癌。
  • 批准号:
    18K07897
  • 财政年份:
    2018
  • 资助金额:
    $ 36.45万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Regulation of acinar cell function
腺泡细胞功能的调节
  • 批准号:
    RGPIN-2018-06444
  • 财政年份:
    2018
  • 资助金额:
    $ 36.45万
  • 项目类别:
    Discovery Grants Program - Individual
Investigation of the role of BRG1 in acinar cell-derived pancreatic tumorigenesis
BRG1 在腺泡细胞源性胰腺肿瘤发生中的作用研究
  • 批准号:
    17H06805
  • 财政年份:
    2017
  • 资助金额:
    $ 36.45万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了